Skip to main content

454 Pays Celoxica $1.5M to Use Its Software In Neandertal Genome Project

NEW YORK (GenomeWeb News) – 454 Life Sciences has used software made by Celoxica Holdings to help it in its project to sequence the Neandertal genome, according to a British online news service.
Life Style Extra cited a Celoxica statement saying that 454 has “invested” $1.5 million in the company’s products, which it uses “to help accelerate the computing performance” of its sequencing technology.

According to LSE, the Celoxica RC2000 board provides the FPGA co-processing engine for the 454 sequencer, and that 454 uses Celoxica's DK Design Suite to program the algorithms in the FPGA.

Officials from 454 were not immediately available to confirm the report.
According to Celoxica's website, the company provides C-based design and behavioral synthesis tools. It provides electronic system level (ESL) co-design products that incorporate ANSI-C, Handel-C, and SystemC languages.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.